Evogene earnings were -$16.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest EVGN earnings report on Dec 31, 2024 announced Q4 2024 earnings of $427.0k, down 105.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EVGN reported annual earnings of -$16.5M, with -31% growth. The next EVGN earnings date is May 21, 2025.
On EVGN's earnings call on Invalid Date, Evogene (NASDAQ: EVGN) reported Q4 2024 earnings per share (EPS) of $0.28, up 121.71% year over year. Total EVGN earnings for the quarter were $427.00 thousand. In the same quarter last year, Evogene's earnings per share (EPS) was -$1.29.
The next EVGN earnings date is Invalid Date. Add EVGN to your watchlist to be reminded of Evogene's next earnings date.
Is Evogene profitable or losing money?
As of the last Evogene earnings report, Evogene is currently losing money. Evogene's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$16.49 million, a 30.96% decrease year over year.
What was EVGN's earnings growth in the past year?
As of Evogene's earnings date in Invalid Date, Evogene's earnings has grown year over year. EVGN earnings in the past year totalled -$16.49 million.
What are Evogene's earnings expectations?
The current EPS estimate for Evogene's earnings report in Invalid Date is -$0.09.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.